Dr. Hossein Baharvand has been recognized as the laureate of 32nd prestigious Khwarizmi International Award. In the award ceremony which has been held on February 4th, 2019, Dr. Hossein Baharvand has been announced as the laureate in the Basic Research field for the development of platforms to generate stem cells-derived cardiomyocytes and hepatocytes in vitro. These two technologies have been developed at Dr. Baharvand’s lab and by active contribution of researchers at Royan Institute for Stem Cell Biology and Technology. Stem cells-derived cardiomyocytes are now produced in large scale for both research purposes as well as preclinical studies to provide sufficient evidence for running clinical trials. The technology of cardiomyocyte differentiation from stem cells are soon going to be implemented at GMP conditions at Royan Institute to provide cell resources for cardiovascular regenerative medicine. Furthermore, stem cells-derived hepatocytes are going to be used for in vitro disease modeling as well as drug testing. These two technologies are soon going to be game changing at both basic research and regenerative medicine.